Chair-based and Standard Exercise Programs in People With COPD

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorIstanbul Medipol University Hospital

About this trial

Patients who are diagnosed with COPD by a pulmonology specialist and referred to pulmonary rehabilitation will be included in the study. Cases that meet the inclusion criteria will be randomized and divided into two groups, standard exercise program group (SGr) and chair-based exercise. program group will be called (ChGr). While standard exercises will be given to SGr, chair-based exercises will be applied to ChGr. All evaluation and initial training sessions of the cases will be held in the hospital. Apart from this, they will be asked to do their exercises at home with the exercise videos that will be sent to them. In order to ensure that home exercises are performed completely and correctly, 2 sessions of online simultaneous exercise training will be provided with a physiotherapist via videoconference on a smartphone, and exercise follow-ups will be carried out by calling once a week. The program duration is 8 weeks, 5 days a week.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Being between the ages of 18-75 years

Having a diagnosis of COPD diagnosed according to clinical diagnostic criteria according to the American Thoracic and European Respiratory Societies (ATS-ERS).

Presence of dyspnea on exertion

Stable clinical status at inclusion without infection or exacerbation in the previous 4 weeks *Having smart phone usage skills

Disqualifiers

Patients with severe comorbid diseases, unstable coronary artery disease, collagen vascular diseases and requiring high-flow oxygen therapy (˃ 3-4 L\min).

A history of exertional syncope or the presence of any comorbidities (such as severe orthopedic or neurological deficits or unstable heart disease) that preclude exercise training.

Having participated in a pulmonary rehabilitation program within the last 12 months.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Standard Exercise Program

    Other intervention

    The program content consists of breathing exercises, upper and lower extremity strengthening with theraband and self-walking. Chest, abdominal and lateral basal breathing exercises will be performed 10 times each. Resistance exercises will be performed as strengthening exercises for the major muscle groups of the upper and lower extremities using medium-hard theraband. Patients will be asked to walk 30 minutes a day on flat ground at 60% workload, for periods calculated according to the 6-minute walk test results (land-based walking).

  • Chair-based Exercise Program

    Other intervention

    The program content consists of breathing exercises and chair-supported exercises. Chest, abdominal and lateral basal breathing exercises will be performed 10 times each. Chair exercises are given in the exercise brochure. Exercises are performed with a chair support or sitting on a chair. In addition, patients will be asked to walk 30 minutes a day on flat ground at 60% workload, for periods calculated according to the 6-minute walk test results (land-based walking).

Treatment groups

64 Participants
are divided into 2 treatment groups
Group A: Chair-based Exercise GroupExperimental treatment 1 intervention
Group B: Standard Exercise GroupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Exercise capacity assesment

The 6-minute walking test will conduct in a 30-meter corridor in line with American Thoracic Society (ATS) guidelines. Participants will ask to walk as far as they can. Prior to and following the test, oxygen saturation, heart rate and Borg fatigue rating will measure, and the walking distance will record.

Time frame
Change from baseline at 2 months

Secondary outcomes

1

Dyspnea evaluation

Modified Medical Council Dyspnea score will rate the sensation of dyspnea as the person perceives it.The severity of dyspnea is rated on a scale of 0 to 4."0 point" means no dyspnea perception and "4point" means severe dyspnea perception.

Time frame
Change from baseline at 2 months
2

Respiratory muscle strength measurement

The mouth pressure measurement (maximum inspiratory and expiratory pressure) will perform with the Pony Fx spirometry device. Patient will place a rubber mouthpiece with flanges, on the device, exhale/inhale slowly and completely, and then will try to breath in as hard as possible. The patient will allow to rest for about a minute and the maneuver will repeat. The aim is that the variability between measurements is less than 10 cm H2O. The maximum value will obtain.

Time frame
Change from baseline at 2 months
3

Peripheral muscle strength measurement

Strength measurements of major peripheral muscle groups will be made with a digital myometer.

Time frame
Change from baseline at 2 months
4

Evaluation of quality of life

Saint George Respiratory Questionaire (SGRQ) score: The SGRQ ranges from 0 (no impairment of quality of life) to 100 (highest impairment of quality of life).

Time frame
Change from baseline at 2 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.